The Medicine Maker / Issues / 2020 / 0720
July 2020

July 2020

In month’s features, we celebrate the grand winners of 2019 Innovation Awards, and expert pathologist Fred Plapp takes a deep-dive into COVID-19 and the state of play. In Business, we look at life sciences insurance, the next wave in the cell therapy field, and how counterfeiters are profiteering from the pandemic. Finally, in Sitting Down With, Bobby Sheng, Chairman, and CEO of Bora Pharmaceuticals, Taiwan, takes a trip down memory lane; outlining his experience of becoming a business leader at just twenty-one years old.

Download PDF
Previous All Issues Next
Manufacture Cell & Gene

Cell Therapy 2.0

July 27, 2020

The first CAR T approvals were a major turning point for the cell therapy field. Now, companies are shifting their focus to the next wave: off-the-shelf (allogeneic) approaches, CAR T and TCR therapy for solid tumors, and combinations with immune checkpoint modulators.

1 min read

Cell Therapy 2.0
Manufacture Drug Discovery Research News Outsourcing Technology & Manufacturing Sponsored

Driving Antibody Drug Discovery Through GenScript ProBio

July 24, 2020

Founded in New Jersey in 2002, GenScript is now truly global, with over 2000 employees, several R&D and manufacturing sites across China, and branch offices in Europe and Japan, as well as the USA. The company’s new segment, GenScript ProBio, has a strong focus on antibody drug discovery and is joined by business units dedicated to cell and gene therapy and biologics. Here, we speak with Liusong Yin, Executive Director of Biologics Discovery Department at GenScript ProBio, to find out more about operations in China.

1 min read

Driving Antibody Drug Discovery Through GenScript ProBio
Manufacture Bioprocessing Biopharma Packaging

Glass Matters

July 21, 2020

The Medicine Maker 2019 Innovation Awards included Schott’s Everic glass vials as a deserved runner up. Biopharmaceuticals are filling company pipelines and many of these drug products are highly sensitive, which means that special consideration must be paid to the primary packaging. Not all glass is created equal and using the right glass and can make a huge difference in terms of reducing unwanted effects between the drug and the packaging, and reducing line downtime through reduced breakage.

1 min read

Glass Matters

Recommended

Recent Issues
May 2025
February 2025
December 2024
October 2024